✦ LIBER ✦

Is electromotive mitomycin C an alternative treatment for frail patients with high-risk non-muscle invasive bladder cancer who have failed intravesical BCG?

✍ Scribed by B.E. Ayres; B.S.I. Montgomery; T. Parker; J. Borwell; N.J. Barber

Book ID: 119200223
Publisher: SAGE Publications
Year: 2009
Tongue: English
Weight: 38 KB
Volume: 2
Category: Article
ISSN: 1875-9742
DOI: 10.1016/j.bjmsu.2009.09.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Contemporary management of patients with

Contemporary management of patients with high-risk non-muscle-invasive bladder cancer who fail intravesical BCG therapy

✍ D. R. Yates; M. Rouprêt 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 197 KB

Contemporary cost-effectiveness analysis

Contemporary cost-effectiveness analysis comparing sequential bacillus Calmette-Guerin and electromotive mitomycin versus bacillus Calmette-Guerin alone for patients with high-risk non-muscle-invasive bladder cancer

✍ Bachir, Bassel G.; Dragomir, Alice; Aprikian, Armen G.; Tanguay, Simon; Fairey, 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

1771 TREATMENT WITH INTRACUTANEOUS AND I

1771 TREATMENT WITH INTRACUTANEOUS AND INTRAVESICAL KEYHOLE LIMPET HEMOCYANIN IS INFERIOR TO INTRAVESICAL MITOMYCIN-C FOR PREVENTION OF RECURRENCES IN PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER: RESULTS FROM A PROSPECTIVE RANDOMIZED PHASE III TRIAL

✍ Lammers, Rianne J.M.; Witjes, Wim P.J.; Janzing-Pastors, Maria H.C.; Caris, Chri 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 121 KB

433 EFFICACY AND SAFETY OF MYCOBACTERIAL

433 EFFICACY AND SAFETY OF MYCOBACTERIAL CELL WALL DNA COMPLEX IN THE TREATMENT OF PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER AT HIGH RISK OF PROGRESSION AND WHO ARE REFRACTORY TO BCG

✍ A. Morales; H.W. Herr; G.D. Steinberg; A.M. Kamat; R. Given; C. Lihou; Z. Cohen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 176 KB